Related references
Note: Only part of the references are listed.Antihypertensive drug effects on long-term blood pressure: an individual-level data meta-analysis of randomised clinical trials
Dexter Canoy et al.
HEART (2022)
Potential Role and Limitations of Estimated Glomerular Filtration Rate Slope Assessment in Cardiovascular Trials A Review
Muhammad Shahzeb Khan et al.
JAMA CARDIOLOGY (2022)
Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium
David E. Kandzari et al.
CIRCULATION (2022)
Cardiovascular Prognosis in Drug-Resistant Hypertension Stratified by 24-Hour Ambulatory Blood Pressure: The JAMP Study
Kazuomi Kario et al.
HYPERTENSION (2021)
TCT-19 Durability of Radio-Frequency Catheter-Based Renal Denervation Associated With Lack of Functional Nerve Recovery at 6 Months in Normotensive Swine Model
Andrew Sharp et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Comparison of Long-Term Outcomes for Responders Versus Non-Responders Following Renal Denervation in Resistant Hypertension
Karl Fengler et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)
Changes in Plasma Renin Activity After Renal Artery Sympathetic Denervation
Felix Mahfoud et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial
Michel Azizi et al.
LANCET (2021)
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure. An individual participant-level data meta-analysis
Denis Pouchain
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2021)
Renal denervation in hypertension patients: Proceedings from an expert consensus roundtable cosponsored by SCAI and NKF
David E. Kandzari et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2021)
Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis
Kazem Rahimi et al.
LANCET (2021)
The REDUCE HTN: REINFORCE Randomized, Sham-Controlled Trial of Bipolar Radiofrequency Renal Denervation for the Treatment of Hypertension
Michael A. Weber et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2020)
Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies
Felix Mahfoud et al.
EUROPEAN HEART JOURNAL (2020)
Review and meta-analysis of renal artery damage following percutaneous renal denervation with radiofrequency renal artery ablation
Raymond R. Townsend et al.
EUROINTERVENTION (2020)
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial
Michael Bohm et al.
LANCET (2020)
Renal Denervation in High-Risk Patients With Hypertension
Felix Mahfoud et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis Practitioner-Based Nationwide JAMP Study
Kazuomi Kario et al.
CIRCULATION (2020)
Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies
Felix Mahfoud et al.
EUROPEAN HEART JOURNAL (2020)
Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry
Felix Mahfoud et al.
EUROPEAN HEART JOURNAL (2019)
Sustained Decrease in Blood Pressure and Reduced Anatomical and Functional Reinnervation of Renal Nerves in Hypertensive Sheep 30 Months After Catheter-Based Renal Denervation
Reetu R. Singh et al.
HYPERTENSION (2019)
2017 ACC/AHA/AAPA/ABC/ACPM/ AGS/APhA/ASH/ASPC/N MA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Paul K. Whelton et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial
David E. Kandzari et al.
LANCET (2018)
Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial
Michel Azizi et al.
LANCET (2018)
2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams et al.
EUROPEAN HEART JOURNAL (2018)
Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension: state of the art and considerations for the future
Felix Mahfoud et al.
EUROPEAN HEART JOURNAL (2017)
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial
Raymond R. Townsend et al.
LANCET (2017)
When and how should multiple imputation be used for handling missing data in randomised clinical trials - a practical guide with flowcharts
Janus Christian Jakobsen et al.
BMC MEDICAL RESEARCH METHODOLOGY (2017)
The SPYRAL HTN Global Clinical Trial Program: Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications
David E. Kandzari et al.
AMERICAN HEART JOURNAL (2016)
Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels - updated overview and meta-analyses of randomized trials
Costas Thomopoulos et al.
JOURNAL OF HYPERTENSION (2016)
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
Dena Ettehad et al.
LANCET (2016)
Blood pressure changes after catheter-based renal denervation are related to reductions in total peripheral resistance
Sebastian Ewen et al.
JOURNAL OF HYPERTENSION (2015)
Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial
Murray D. Esler et al.
EUROPEAN HEART JOURNAL (2014)
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014)
HYPERTENSION RESEARCH (2014)
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
Henry Krum et al.
LANCET (2009)
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2006)
Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure
G Mancia et al.
HYPERTENSION (2006)
Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives - A prospective study
K Kario et al.
CIRCULATION (2003)
Share Paper
